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doi:10.1Objective: Because the left atrial appendage is thought to be a major source of stroke in patients with atrial
fibrillation, a new device and technique were developed for thoracoscopic isolation of the left atrial append-
age.
Methods: The left and right atrial appendages were approached from an 11.5-mm port in the left thorax in 15
canines. With an atraumatic grasper for appendage positioning, expandable silicone bands covered with polyester
fabric were placed at the base of the left and right atrial appendages. The location of the bands was marked with
radiopaque clips to assess migration, and radiopaque dye was injected to confirm occlusion. The animals were
killed at 1 week (n ¼ 3), 2 weeks (n ¼ 6), or 12 weeks (n ¼ 6).
Results: The bands were deployed on 30 appendages without complications. The appendages were 100%
occluded, and there was no migration of any bands at death. There was no indication of bleeding, rupture, or sys-
temic emboli in any of the 15 animals. Following complete occlusion, the appendages became necrotic and were
replaced by scar tissue. The healed atrial surface was consistently smooth and devoid of thrombus. There was
evidence of mild-to-moderate inflammation associated with a foreign body–type reaction to the fabric material
but no pericarditis.
Conclusions: Permanent occlusion of the left atrial appendage is feasible via a thoracoscopic epicardial approach
with this novel silicone band. As the atrial tissue becomes necrotic, the silicone band continues to constrict, en-
suring that the appendage remains isolated. Band occlusion of the left atrial appendage could potentially improve
overall treatment outcome in patients at high risk of atrial thrombus formation. (J Thorac Cardiovasc Surg
2010;140:885-9)E
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SThe left atrial appendage (LAA) is a common site of thrombus
formation in patients with cardiovascular disease.1,2 Surgical
exclusion of the LAA is recommended in the current
American Heart Association/American College of Cardiol-
ogy guidelines for patients with mitral valve disease at the
time of mitral valve surgery.3 Recently, the Left Atrial
Appendage Occlusion Study demonstrated that the use of
sutures or a stapling device to occlude the LAA at the time
of coronary artery bypass grafting could be performedwithout
increasing the duration of cardiopulmonary bypass or the risk
of postoperative complications.4 Although surgical tech-
niques to excise or isolate the LAA are easy to apply, the
reproducibility and efficacy of the techniques available have
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The Journal of Thoracic and Cathat surgical ligation of the LAA with a running suture in
50 patients undergoing mitral valve surgery was only effec-
tive in excluding the LAA in 64% of the patients. Further-
more, Garcı´a-Ferna´ndez and colleagues6 ligated the LAA
by using a double-suture technique at the time of mitral valve
replacement surgery in 58 patients and found that ligationwas
incomplete in 6 patients. A more recent study by Kanderian
and colleagues7 compared the success rate of surgical exci-
sion of the LAA with suture or stapler exclusion in 137 pa-
tients undergoing open-heart surgery. They reported that
successful closure occurred more often with excision (73%)
than with suture exclusion (23%) or stapler exclusion (0%).
In addition to surgical exclusion of the LAA via an open-
chest approach, a thoracoscopic approach has been used to
obliterate the LAA.8,9 Thoracoscopic LAA exclusion has
been performedwith both a loop snare and a stapler in a small
number of patients.9 A thoracoscopic epicardial approach
has the potential advantages of simplicity and a low proce-
dural risk of embolism; however, there is a need for a device
to facilitate rapid, reliable, and safe epicardial occlusion of
the LAA. Therefore the goal of the present study was to de-
velop a new epicardial band occlusion device and investi-
gate its utility to occlude canine atrial appendages. An
additional objective was to investigate the long-term (up to
12 weeks) healing response of the atria and appendages after
band occlusion.rdiovascular Surgery c Volume 140, Number 4 885
FIGURE 1. Photographs of the delivery device and occlusive band. The
delivery device is shown with the preloaded, polyester fabric–covered sili-
cone band. The inset shows a close-up view of the occlusion band after re-
lease from the delivery device.
Abbreviations and Acronyms
LAA ¼ left atrial appendage
RAA ¼ right atrial appendage
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Delivery Device and Silicone Band
A thoracoscopic device made of acrylonitrile butadiene styrene, stainless
steel, and polytetrafluoroethylene was used to deliver an expandable sili-
cone band (0.225 inch) around the base of the atrial appendage (Figure 1).
The band was attached to the distal end of the delivery device by a Nitinol
wire. After the deployment of the band, the Nitinol wire and delivery device
were removed from the surgical site. The occlusion bands were rectangular
in cross-sectional shape, white in color, andmade of silicone embeddedwith
BaSO4. The bands were covered with polyester fabric to reduce the possi-
bility of migration after implantation. The ‘‘hole’’ in the middle of the
band is 5.7 mm when released.Implant Procedure
Silicone bands were implanted in 15 adult mongrel dogs of either sex
weighing 25 to 34 kg. All animals have received humane care in compliance
with the guide for the care and use of laboratory animals and the protocol
was approved by the Institutional Animal Care and Use Committee. All pro-
cedures and animal housing were at Medtronic’s Physiological Research
Laboratories. An analgesic and sedative (morphine and acepromazine)
was given to each animal before the induction of anesthesia. The animals
were induced with propofol, intubated, and then ventilated with isoflurane
(1.5% to 3%) to maintain a surgical plane of anesthesia. The left atrial ap-
pendate (LAA) and right atrial appendage (RAA) were approached from an
11.5-mm port in the left fourth intercostal space. Baseline images of the
RAA and LAA and the surgical procedure were recorded by means of thor-
acoscopic video. An atraumatic grasper was used to position the appendage
so an expandable occlusion band (0.225 inch ID) could be placed at the base
of each appendage. The occlusion band was positioned and deployed on
both atrial appendages using a thoracoscopic delivery device (Figure 1).
The occlusion was assessed visually by ascertaining that the band caused
isolation of the appendage. There were no instances of hemodynamic insta-
bility. Hemoclips were placed on the proximal side of the band after implan-
tation to mark the position of the band. A pigtail catheter was introduced into
the right atrium through jugular access for the administration of radiopaque
dye. Fluoroscopic images of the heart were obtained during dye injection
before and after implantation to determine the completeness of occlusion.
Animals recovered under the supervision of a veterinarian and were given
aspirin (81 mg administered orally) and dipyridamole (50 mg administered
orally) daily for 1 week after implantation. Animals receiving implants were
killed after 1 week (n¼ 3), 2 weeks (n¼ 6), or 12 weeks (n¼ 6). Additional
fluoroscopic images were obtained just before death.FIGURE 2. Fluoroscopic images of right atriumwith dye injection before (A), im
vena cava; IVC, inferior vena cava; RAA, right atrial appendage; RA, right atriu
886 The Journal of Thoracic and Cardiovascular SurgPathology and Histology
Following termination, the kidneys, liver, lungs, and brain from each an-
imal were grossly examined, and representative samples of each organ were
fixed in 10% neutral buffered formalin. The endocardial and epicardial
aspects of each heart were grossly examined. If the band was not located at
the base of the appendage, the distance to the previously placed hemoclips
was recorded. The left and right atria, with the bands in situ, were dissected
away from the heart and fixed in 10% neutral buffered formalin. After fixa-
tion, each appendage remnant was bisected to assess the cross-sectional
appearance of the tissues. The appendage tissues were serially sampled for
evaluation of the occluded appendages, tissues through the constricted
zone, and the appendage/atrial tissue proximal to the constricted zone. All
fixed tissue samples were routinely processed, paraffin embedded, sectioned
via microtome at 4 mm thickness, and mounted on glass slides for light
microscopy examination. Appendage sections were stained with hematoxy-
lin and eosin and Masson’s trichrome and evaluated for fibrosis, inflamma-
tion, remaining cardiac tissue, and the presence of any thrombotic material
on the endocardial surface, with documentation of any additional pathology.
Sections of other organs were stained with hematoxylin and eosin and eval-
uated for vascular thromboembolism, with documentation of any additional
pathology.RESULTS
Bands were placed without complication on all the ap-
pendages; 2 bands were placed on 1 appendage each (1
RAA and 1 LAA) in 2 animals. The extra band on the
RAA of one animal was placed intentionally to determine
the feasibility of placing a second band. A second band on
the LAA in one animal was necessary because the first
band was not placed all the way at the base of the appendage.
Fluoroscopic images obtained during the injection of radi-
opaque dye before and after band implantation showed
that occlusion was 100% effective in both the RAA andmediately after (B), and 2 weeks after (C) band implantation. SVC, Superior
m; RV, right ventricle.
ery c October 2010
FIGURE 3. Fluoroscopic images of the heart at implantation (A) 1 week (B) and 12 weeks (C) after implantation. The left atrial bands are indicated by white
arrows, and the right atrial bands are indicated by black arrows. Hemoclips placed on the left and right atria are indicated by white and black triangles, re-
spectively.
FIGURE 4. Gross pathology 12 weeks after implantation of polyester fabric–covered bands. A, Left atrial appendage overview. B, Opened left atrium. The
arrow points to the endocardial occlusion site. C, Bisected left atrial appendage and occluding band. D, Right atrial appendage overview. E, Opened right
atrium. F, Bisected right atrial appendage and occluding band.
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FIGURE 5. Histopathology of the left and right atrial appendages at 12 weeks after implantation of polyester fabric–covered bands. The tissue was stained
with Masson’s trichrome stain. R, Appendage remnant; F, band fabric; V, band void; A, atrium.
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SLAA in all 15 dogs (Figure 2). Additional images during dye
injection at the time of death verified that the occlusion was
maintained over the duration of follow-up. Fluoroscopic im-
ages obtained without dye injection showed that there was
no band migration at any time after deployment (Figure 3).
Gross Pathology
A gross pathologic examination was performed in each
animal after death (Figure 4). The bands and appendage rem-
nants were encapsulated by fibrous adhesions. At 12 weeks,
the adhesions were very stable and could not be moved with
moderate tension. No pericarditis or other medical complica-
tions from tissue abrasion caused by the implant were ob-
served. The atrial appendages became necrotic, and the
appendage remnant distal to the occluding bands was consis-
tently small, firm, and pale compared with the atrial tissue
proximal to the bands. On the atrial endocardial surface,
the occlusion site generally consisted of folded or puckered
tissue, with red discoloration (endocardial congestion and
hemorrhage) delineating the border between the proximal
viable tissue and the distal banded tissue. All of the occlu-
sion sites were closed at necropsy with the band in place,
with no opening to the appendage from the atrium. No
cracks in or other damage to the bands were observed during
postexplant inspection.
Histopathology
A fibrous scar sealing each appendage remnant was intact
and lined by endothelium, with no thrombotic material ob-
served (Figure 5). Cardiac myocytes within the atrial wall
at the scar boundary were often atrophied, with clusters of
myocytes occasionally isolated by fibrocollagenous tissue.888 The Journal of Thoracic and Cardiovascular SurgMild chronic inflammation was occasionally observed
within vascular areas of the fibrous atrial scar but did not ex-
tend into atrial cardiac tissue. Connective tissue forming the
scar had areas of chondroid deposition, cartilage, and bone
formation. In addition, no intravascular thromboemboli
were observed in tissue sections of the lung, liver, left and
right kidneys, or brain.
DISCUSSION
The goal of this study was to develop and evaluate a novel
band occlusion device that could be used to isolate the atrial
appendage. The band and associated delivery tool that were
developed could be rapidly deployed from a thoracoscopic
approach but could also be deployed through a sternotomy
or other surgical incision. Importantly, there were no major
complications associated with deployment of the occlusive
bands and no migration of the bands over time. The polyes-
ter fabric–coated bands used in the present study were asso-
ciated with adhesions; however, there was no pericarditis or
other medical complications from tissue abrasion caused by
the implants. Furthermore, the most important finding of the
present study was that band implantation resulted in 100%
exclusion of the RAA and LAA from the rest of the atria.
The success of exclusion was confirmed by means of
both radiopaque dye injection and direct postmortem exam-
ination.
Postmortem examination showed that the atrial append-
ages became necrotic and the appendage remnant distal to
the occluding bands was consistently small, firm, and pale
compared with the atrial tissue proximal to the bands. On
the atrial endocardial surface, the occlusion site generally
consisted of folded or puckered tissue, with redery c October 2010
McCarthy et al Evolving Technology/Basic Sciencediscoloration delineating the border between the proximal
viable tissue and the distal banded tissue. Histopathology
showed a fibrous scar sealing each appendage remnant
that was lined by endothelium. Although the only antico-
agulant given to the animals was 81 mg of aspirin for 1
week after implantation, no thrombotic material was
observed.
The rate of complete exclusion of the LAA observed with
band occlusion in the present study is higher than the rate of
complete occlusion by suture or staple exclusion of the
LAA in patients reported by Kanderian and coworkers.7 Al-
though band occlusion was not compared with suture or sta-
pler exclusion in the present study, band occlusion might be
superior because the band continues to apply circumferen-
tial force to the atrial appendage as the tissue becomes
necrotic.
A limitation of the present study is that the occlusive
bands were applied to normal atria in healthy canines. Pa-
tients who would be candidates for surgical atrial exclu-
sion often have enlarged left atria10 and might require
a band with a larger diameter than the bands used on the
canine atria in the present study. Furthermore, the append-
ages of older patients with various comorbidities might be
more friable and prone to tearing than those of the rela-
tively young and healthy canines used in this study. Future
studies will investigate the band occlusion method for
larger and broader-based appendages more representative
of the size of the LAA in patients. Indeed, a multicenter
phase II clinical trial is currently underway in the United
States to demonstrate successful occlusion in human
subjects.
CONCLUSIONS
Permanent occlusion of the LAA is feasible via a thoraco-
scopic epicardial approach with this novel banding tech-The Journal of Thoracic and Canique. As the atrial tissue becomes necrotic, the silicone
band continues to constrict, ensuring that the appendage re-
mains isolated. Band occlusion of the LAA could potentially
improve overall treatment outcomes in patients at high risk
of atrial thrombus formation.References
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